Name: Noopept Powder, Capsules, &amp; Sublingual Solution
SKU: 4330
Availability: InStock
Rating: 4.56 (44 reviews)

Product Description

Noopept is a synthetic nootropic molecule grouped in the racetam class but structurally different from racetams.

Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) lacks a 2-oxo-pyrollidine nucleus that a true racetam is defined by (ref)*
Synthesized in 1996 (ref)*
Assured Purity: Rigorously tested for quality & purity by third-party Certificate of Analysis*

Noopept Chemical Properties

In animal research, Noopept may increase alpha waves in the brain similarly to the function of Piracetam; however, Noopept also increases beta waves and decreases delta waves. In animals, Noopept is believed to work with acetylcholine and neurotrophin in the brain, although it is not entirely understood (1).

Noopept’s molecular formula is C₁₇H₂₂N₂O₄ and it has a molecular mass of 318.373 g/mol (2).

It is also known as GVS-111 and the CAS number is 157115-85-0 (2).

Noopept Powder, Capsules and Sublingual

Pure Nootropics offers Noopept in 20 mg capsules or 15 g bulk powder quantities or 60 ml sublingual preparation.

Noopept Toxicity

In mice, doses of 10-100 mg/kg did not induce any irreversible toxic changes (3).

For further information, please see our References Tab above.

Additional Information

Weight	0.18125 lbs
Dimensions	1.25 × 1.25 × 3.95 in
Quantity	15g, 30g, Sublingual Kiwi Strawberry (60 x 10mg), Capsules ( 90 x 20mg )

The references below are not meant to imply that any of our products treat, cure, or diagnose any disease or human condition. This product is sold as a research chemical and is for research purposes only; we recommend consulting a professional about how to handle this chemical. References to clinical studies and pre-clinical studies may use varying dosages and may not represent the dosages or subsequent results of products we sell; however, the references provided are pertinent to the subject supplement itself. References provided are intended for research and informational purposes only and do not represent the entire body of knowledge available on the subject(s) referenced; nor do they represent all possible outcomes associated with the subject(s) referenced including, but not limited to, adverse effects, precautions, or chemical interactions within the human body. The Content provided on this website is not intended to be a replacement for professional medical advice, treatment or diagnosis. Never ignore the advice of a medical professional or delay in attaining professional advice because of information or impressions you gather on this website. Choosing to rely on any information provided by the Content of this website is solely at your own risk. We encourage our audience to do their own research beyond the resources we have provided so your decision is as educated as possible.

• Noopept (N-phenylacetyl-L-prolylglycine ethyl ester) lacks a 2-oxo-pyrollidine nucleus that a true racetam is defined by*
“Noopept.” Examine.com, published on Oct 5, 2014. Last Updated Jun 14, 2018. https://examine.com/supplements/noopept/.
• Synthesized in 1996*
“Noopept.” Examine.com, published on Oct 5, 2014. Last Updated Jun 14, 2018. https://examine.com/supplements/noopept/.
1. “Noopept.” Examine.com, published on Oct 5, 2014. Last Updated Jun 14, 2018. https://examine.com/supplements/noopept/.
2. “Noopept.” PubChem Open Chemistry Database, pubchem.ncbi.nlm.nih.gov/compound/Noopept#section=Wikipedia.
3. Kovalenko, LP, et al. “[Preclinical Study of Noopept Toxicity].” Eksp Klin Farmakol, vol. 65, no. 1, 2002, pp. 62–4., www.ncbi.nlm.nih.gov/pubmed/12025790.

NOOPEPT CERTIFICATE OF ANALYSIS 05/2019

NOOPEPT CERTIFICATE OF ANALYSIS 02/2019

NOOPEPT CERTIFICATE OF ANALYSIS 02/2018